Findings of Research Misconduct, 8304 [E6-2235]

Download as PDF 8304 Federal Register / Vol. 71, No. 32 / Thursday, February 16, 2006 / Notices North Pearl Street, Dallas, Texas 752012272: 1. Frontier Bancshares, Inc., Austin, Texas; to become a bank holding company by acquiring 100 percent of the voting shares of Frontier BN, Inc., Henderson, Nevada, and The First National Bank of Holland, Holland, Texas. In addition, Frontier BN, Inc. Henderson, Nevada, also has applied to become a bank holding company by acquiring 100 percent of the voting shares of First National Bank of Holland, Holland, Texas. and was given thirty (30) days to contest the finding and the proposed administrative action. The thirty-day period has elapsed and ORI has not received a response. Accordingly, the following administrative action has been implemented for a period of three (3) years, beginning on January 18, 2006: (1) Ms. Goldring is prohibited from serving in any advisory capacity to PHS, including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. FOR FURTHER INFORMATION CONTACT: Board of Governors of the Federal Reserve System, February 13, 2006. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E6–2236 Filed 2–15–06; 8:45 am] Director, Division of Research Investigations, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453– 8800. BILLING CODE 6210–01–S Chris B. Pascal, Director, Office of Research Integrity. [FR Doc. E6–2234 Filed 2–15–06; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4160–17–P Office of the Secretary DEPARTMENT OF HEALTH AND HUMAN SERVICES Findings of Scientific Misconduct Office of the Secretary, HHS. Notice. AGENCY: dsatterwhite on PROD1PC65 with NOTICES ACTION: Office of the Secretary SUMMARY: Notice is hereby given that the Office of Research Integrity (ORI), the Assistant Secretary for Health, and another Federal agency have taken final action in the following case: Amy Beth Goldring, University of California at Los Angeles: Based on an investigation conducted by the University of California at Los Angeles (UCLA) and additional analysis conducted by the Office of Research Integrity (ORI) in its oversight review, ORI found that Ms. Goldring, former graduate student, Department of Psychology, UCLA, engaged in scientific misconduct by falsifying or fabricating data and statistical results for up to nine pilot studies on the impact of vulnerability on decision-making from Fall 2000 to Winter 2002 as a basis for her doctoral thesis research. The falsified or fabricated data was included in a manuscript submitted to Psychological Science, in National Institutes of Mental Health (NIMH), National Institutes of Health (NIH), grant application 1 R01 MH65238– 01A1, and in NIMH, NIH, pre-doctoral training grant T32 MH15750. Ms. Goldring has been debarred by another agency with joint jurisdiction for a period of three (3) years, beginning on May 13, 2005, and ending on May 13, 2008. On December 16, 2005, Ms. Goldring received a detailed explanation of ORI’s proposed finding VerDate Aug<31>2005 15:56 Feb 15, 2006 Jkt 208001 three (3) years, beginning on January 13, 2006: (1) Ms. Swe has been debarred from eligibility for or involvement as a principal in nonprocurement transactions (e.g., grants and cooperative agreements) of the Federal Government and from contracting or subcontracting with any Federal Government agency, except as provided in 45 CFR 76.120. This action is being taken pursuant to the debarment regulations at 45 CFR part 76. (2) Ms. Swe has been prohibited from serving in any advisory capacity to PHS including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as consultant. FOR FURTHER INFORMATION CONTACT: Director, Division of Research Investigations, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453– 8800. Chris B. Pascal, Director, Office of Research Integrity. [FR Doc. E6–2235 Filed 2–15–06; 8:45 am] BILLING CODE 4160–17–P Findings of Research Misconduct Office of the Secretary, HHS. Notice. AGENCY: ACTION: SUMMARY: Notice is hereby given that on January 13, 2006, the Department of Health and Human Services (HHS) Debarring Official, on behalf of the Secretary of HHS, issued a final notice of debarment based on the research misconduct findings of the U.S. Public Health Service (PHS) in the following case: April Swe, University of WisconsinMadison: Based on the report of an investigation conducted by the University of Wisconsin-Madison (UWM) and additional analysis conducted by the Office of Research Integrity (ORI) in its oversight review, PHS found that Ms. Swe, former graduate student at UWM, engaged in research misconduct by fabricating data on thirty-nine (39) questionnaires of sibling human subjects associated with an autism study. The research was supported by National Institute on Aging, National Institutes of Health (NIH), grant R01 AG08768. In a final decision dated January 13, 2006, the HHS Debarring Official, on behalf of the Secretary of HHS, issued the final debarment notice based on the PHS findings of research misconduct. The following administrative actions have been implemented for a period of PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [30Day–06–05AY] Agency Forms Undergoing Paperwork Reduction Act Review The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. Chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639–4766 or send an email to omb@cdc.gov. Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395–6974. Written comments should be received within 30 days of this notice. Proposed Project Economic Evaluation Of Walking Behavior In Sedentary Adults Age 50 Years And Older—New—National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC). E:\FR\FM\16FEN1.SGM 16FEN1

Agencies

[Federal Register Volume 71, Number 32 (Thursday, February 16, 2006)]
[Notices]
[Page 8304]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-2235]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Research Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that on January 13, 2006, the 
Department of Health and Human Services (HHS) Debarring Official, on 
behalf of the Secretary of HHS, issued a final notice of debarment 
based on the research misconduct findings of the U.S. Public Health 
Service (PHS) in the following case:
    April Swe, University of Wisconsin-Madison: Based on the report of 
an investigation conducted by the University of Wisconsin-Madison (UWM) 
and additional analysis conducted by the Office of Research Integrity 
(ORI) in its oversight review, PHS found that Ms. Swe, former graduate 
student at UWM, engaged in research misconduct by fabricating data on 
thirty-nine (39) questionnaires of sibling human subjects associated 
with an autism study. The research was supported by National Institute 
on Aging, National Institutes of Health (NIH), grant R01 AG08768.
    In a final decision dated January 13, 2006, the HHS Debarring 
Official, on behalf of the Secretary of HHS, issued the final debarment 
notice based on the PHS findings of research misconduct. The following 
administrative actions have been implemented for a period of three (3) 
years, beginning on January 13, 2006:
    (1) Ms. Swe has been debarred from eligibility for or involvement 
as a principal in nonprocurement transactions (e.g., grants and 
cooperative agreements) of the Federal Government and from contracting 
or subcontracting with any Federal Government agency, except as 
provided in 45 CFR 76.120. This action is being taken pursuant to the 
debarment regulations at 45 CFR part 76.
    (2) Ms. Swe has been prohibited from serving in any advisory 
capacity to PHS including but not limited to service on any PHS 
advisory committee, board, and/or peer review committee, or as 
consultant.

FOR FURTHER INFORMATION CONTACT: Director, Division of Research 
Investigations, Office of Research Integrity, 1101 Wootton Parkway, 
Suite 750, Rockville, MD 20852, (240) 453-8800.

Chris B. Pascal,
Director, Office of Research Integrity.
[FR Doc. E6-2235 Filed 2-15-06; 8:45 am]
BILLING CODE 4160-17-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.